Yukin Therapeutics

Become the referent of this startup

Yukin Therapeutics develops NF-kappa-B-inducing kinase (NIK) inhibitors for targeted therapies in oncology with a focus on skin and pancreatic cancers.
Automatic translation

Technologies

  • DEEPTECH

Activity area

  • HEALTHTECH
  • ONCOLOGY
  • BIOTECH
  • IMMUNOLOGY

Maturity stage

  • Early bird

Key information

Year of creation

2019

Workforce

< 10

Maturity stage

Early bird

Total fundraising amount

3 300 000 €

Last round table level

Investment

Total fundraising amount

3 300 000 €

Maximum round table reached

Date Amount Investors Round table
01/07/2019 3 300 000,00 €

Similar start-ups